Sciencast Management’s Abiomed Inc ABMD Stock Holding History

Sciencast Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$287K	Buy	+988	New	+$267K	0.06%	320
2021 Q3	–	Sell	-2,309	Closed	-$748K	–	659
2021 Q2	$748K	Buy	+2,309	New	+$708K	0.16%	195
2020 Q3	–	Sell	-1,519	Closed	-$395K	–	594
2020 Q2	$395K	Sell	1,519 -181	-11%	-$36.3K	0.1%	302
2020 Q1	$246K	Buy	+1,700	New	+$282K	0.07%	209
2019 Q4	–	Sell	-2,419	Closed	-$417K	–	639
2019 Q3	$417K	Buy	+2,419	New	+$523K	0.14%	237
2019 Q2	–	Sell	-4,305	Closed	-$1.22M	–	506
2019 Q1	$1.22M	Buy	+4,305	New	+$1.43M	0.43%	80
2016 Q3	–	Sell	-5,904	Closed	-$645K	–	289
2016 Q2	$645K	Buy	5,904 +2,604	+79%	+$259K	0.28%	119
2016 Q1	$313K	Buy	+3,300	New	+$279K	0.25%	136

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sciencast Management's ABMD Position: Q2 2022 in Review

Sciencast Management opened a new position in Abiomed Inc (ABMD) in Q2 2022: 988 shares worth $287K. The stake represents 0.06% of the portfolio and ranks #320 among its holdings. This is a return to the name: Sciencast Management previously reported a position in ABMD as recently as Q2 2021.

Sciencast Management first reported a position in ABMD in Q1 2016 and has held it in 8 quarters since. The position peaked at $1.22M in Q1 2019. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Sciencast Management held 988 shares of Abiomed Inc worth $287K as of Q2 2022.
Abiomed Inc was a new Sciencast Management position in Q2 2022.
Abiomed Inc made up 0.06% of Sciencast Management's portfolio in Q2 2022, its #320 holding.
Sciencast Management first reported a position in Abiomed Inc in Q1 2016 and has held it in 8 quarters since.
Sciencast Management's Abiomed Inc position peaked at $1.22M in Q1 2019.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.